(MedPage Today) — HOUSTON — SGLT2 inhibitors may hold a benefit for a wider pool of patients with chronic kidney disease (CKD) than previously thought, a pair of meta-analyses indicated.
SGLT2 inhibitors helped to slow the progression of CKD…
Source link : https://www.medpagetoday.com/meetingcoverage/asn/118388
Author :
Publish date : 2025-11-08 15:06:00
Copyright for syndicated content belongs to the linked Source.
